Antonio Alejandro De Miguel Castro

Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.

A. Tello-Montoliu, M. Valdés Chávarri, I. Cruz González, 2019, JACC. Cardiovascular interventions.

Letter by De Miguel Castro et al regarding article, "Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the gauging responsiveness with a VerifyNow P2Y12 assay: impact on Thrombosis and Safety (GRAVITAS) trial".

A. Pérez de Prado, Antonio Alejandro De Miguel Castro, Alejandro Diego Nieto, 2012, Circulation.

Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome.

A. Pérez de Prado, A. Diego Nieto, Antonio Alejandro De Miguel Castro, 2009, Revista espanola de cardiologia.

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study

C. Macaya, A. Regueiro, J. Escaned, 2021, Cardiovascular Revascularization Medicine.

Letter by de Miguel Castro et al regarding article, "cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up".

A. Pérez de Prado, A. Diego Nieto, Antonio Alejandro De Miguel Castro, 2009, Circulation.

Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry.

A. Regueiro, J. Escaned, I. Amat-Santos, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Letter by de Miguel Castro et al regarding article, "cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up".

A. Pérez de Prado, A. Diego Nieto, Antonio Alejandro De Miguel Castro, 2009, Circulation.

Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome.

A. Pérez de Prado, A. Diego Nieto, Antonio Alejandro De Miguel Castro, 2009, Revista espanola de cardiologia.